Kansas City Royals infielder Miguel Tejada, suspended for 105 games last week because of positive tests for amphetamine use this season, was also implicated in the Biogenesis investigation, sources familiar with the case confirmed to ESPN.
Major League Baseball had the choice of going after the 2002 American League MVP for the Biogenesis case, as the league did 13 other players earlier this month, or for the amphetamine case. MLB chose to suspend Tejada after he tested positive for a third time in his career for amphetamines.
Tejada, according to a source familiar with the case, was given the choice of either accepting the 105-game suspension for amphetamine use or facing additional punishment for his Biogenesis connection. Tejada was allegedly a customer of Tony Bosch’s shuttered clinic, which is at the heart of baseball’s recent rash of suspensions. Bosch supplied evidence that Tejada had been a Biogenesis customer.
Tejada said he had a therapeutic use exemption for the drug Adderall. The MLB Players Association reportedly argued that Tejada’s TUE had expired in April and that he should have been allowed to continue to play while applying for an extension. MLB disagreed and Tejada did not fight the suspension.
Posted: August 20, 2013 at 05:39 AM | 59 comment(s)
Login to Bookmark